As a specialty contract research organization (CRO), Clinilabs offers a full portfolio of clinical drug development services to its clients. These include all of the services sponsors expect from a premier CRO, encompassing multicenter project management, investigator and subject recruitment, clinical and medical monitoring, data management, biostatistics, and medical writing. One unique aspect of the Company is its core data center. This center offers the centralized capture of electronic source documents and case report forms (eCRFs), and the central reading of polysomnograms (PSGs), electroencephalograms (EEGs), and electrocardiograms (ECGs) for multicenter trials. Our ability to manage domestic and global trials using the advanced technology in our core data center allows us to provide unparalleled value to clients.
Complex Phase I and proof-of concept studies can be conducted at Clinilabs’ state-of-the-art, 68-bed clinic in Manhattan, which offers an ideal location for timely recruitment of healthy volunteers, special populations (e.g., Japanese and Chinese), and patients. In addition, pharmacokinetic, pharmacodynamic, and biomarker studies, as well as those that require thorough QT or specialized cardiac assessment, are areas of Clinilabs’ expertise.
Established in 2001, Clinilabs has provided services to more than one third of the world’s top 20 pharmaceutical companies, and has been involved in more than 7 successful New Drug Applications (NDAs) in central nervous system (CNS) and cardiovascular (CV) indications. Clinilabs’ mission is to provide high-quality, prompt, and cost-effective services to its clients in the interest of delivering new therapeutics to those in need.
|
